Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Endeavor BioMedicines | 2024 | Series C | Undisclosed | Solana Beach |
| Prelude Therapeutics | 2026 | Post-IPO Equity | Undisclosed | Wilmington |
| Revolution Medicines | 2026 | Post-IPO Equity | Undisclosed | Redwood City |
| T1 Energy | 2026 | Post-IPO Debt | Undisclosed | Austin |
| Corastone | 2026 | Series Unknown | Undisclosed | Houston |
| Menlo Micro | 2022 | Series C | Undisclosed | Irvine |
| Heartflow | 2025 | Convertible Note | Undisclosed | Mountain View |
| Generation Bio | 2023 | Post-IPO Equity | Undisclosed | Cambridge |
| LifeMine Therapeutics | 2022 | Series C | Undisclosed | Cambridge |
| Local Bounti | 2026 | Post-IPO Debt | Undisclosed | Hamilton |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Endeavor BioMedicines | Series C | Undisclosed | Solana Beach, United States |
| 27 | Prelude Therapeutics | Post-IPO Equity | Undisclosed | Wilmington, United States |
| 28 | Revolution Medicines | Post-IPO Equity | Undisclosed | Redwood City, United States |
| 29 | T1 Energy | Post-IPO Debt | Undisclosed | Austin, United States |
| 30 | Corastone | Series Unknown | Undisclosed | Houston, United States |
| 31 | Menlo Micro | Series C | Undisclosed | Irvine, United States |
| 32 | Heartflow | Convertible Note | Undisclosed | Mountain View, United States |
| 33 | Generation Bio | Post-IPO Equity | Undisclosed | Cambridge, United States |
| 34 | LifeMine Therapeutics | Series C | Undisclosed | Cambridge, United States |
| 35 | Local Bounti | Post-IPO Debt | Undisclosed | Hamilton, United States |
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
T1 Energy is a solar and battery manufacturing company for commercial and industrial sectors.
Corastone is a technology company that provides infrastructure for private-market investing.
Menlo Micro is the developer of the Ideal Switch, an electromechanical switch technology used to switch AC/DC and RF.
Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Local Bounti is an agriculture company delivering herbs, vegetables, and other products to service wholesale restaurant and grocer accounts.
AppHarvest is a sustainability company that operates and develops robust, climate-resilient indoor farms.
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
Redwood Materials is a battery recycling startup that makes electric vehicles and sustainable materials for circular supply chains.
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Glide Identity provides SIM-based cryptographic authentication and verification systems using telecom network APIs.
Skyryse is a manufacturing firm that offers aerospace hardware and software operating systems and components design, production, and sales.
Empower Semiconductor is a technology company enabling the design of high efficiency, integrated voltage regulators in SoCs.
Moby provides regular investors access to tactics that were previously only available to Wall Street's behemoths.
ZILO's mission is to innovate and deliver transformative technology that enables organisations to operate more efficiently.
Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.
Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.
Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies
Conformal Medical is an early stage medical device company developing devices to prevent stroke in patients.
Farmers Business Network is a digital marketplace that helps farmers buy inputs, access financing, and join marketing programs.
Fidelity has invested in 209 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Fidelity's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Financial Services. The firm invests across 58 different industry categories.
Among tracked funding rounds, Redwood Materials received $350.0M in a Series E round. Fidelity's total known invested capital is $15.5B.
Fidelity's average investment size is $140.8M across its portfolio of 209 companies.
Recent Fidelity portfolio additions include Endeavor BioMedicines, Prelude Therapeutics, Revolution Medicines, T1 Energy, Corastone. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors